V940 (intismeran autogene) The official scientific designation for Moderna & Merck’s personalized mRNA neoantigen therapy. Successfully completed Phase 3 (INTerpath-001) for high-risk melanoma. Precision-engineered from each patient’s unique tumor mutations. The future of individualized cancer treatment is here.
Score | 1 |
|---|---|
24h Vol | $0 |
Liquidity | $2.1K |
Holders | N/A |
Audits | |
Age | 2 days |
FDV | $2.3K |
Market Cap | $2.3K |
| Addresses | |
|---|---|
| Pool | |
| V940 | |
| SOL |  |
| Developer |
V940 to SOL Converter
Score | 1 |
|---|---|
24h Vol | $0 |
Liquidity | $2.1K |
Holders | N/A |
Audits | |
Age | 2 days |
FDV | $2.3K |
Market Cap | $2.3K |
About The Cancer Vaccine (V940)
V940 (intismeran autogene) The official scientific designation for Moderna & Merck’s personalized mRNA neoantigen therapy. Successfully completed Phase 3 (INTerpath-001) for high-risk melanoma. Precision-engineered from each patient’s unique tumor mutations. The future of individualized cancer treatment is here.
Update Token InfoV940/SOL Price Stats
The current price of V940 (V940/SOL) on Pump.fun is $0.000002307, the price is up 0% in the last 24 hours. Its 24-hour trading volume is reported to be at $0.00 with a total of 0 transactions. V940/SOL contract address is EdedTbP1qFwSjJWjE4rYcNe3PtjW4qUA48XzkDi2qtGo, with a Fully Diluted Valuation (FDV) of $2,307.30 and a liquidity pool of $2,119.03.
